TrialGut2013

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104).

Volker Heinemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.